Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel
you are here: HomeNewsEconomyPolicy
Last Updated : May 29, 2020 05:07 PM IST | Source: Moneycontrol.com

Government mulls further measures for NBFCs, markets: Report

At a meeting chaired by FM Sitharaman, RBI officials raised concerns over liquidity challenges being faced by NBFCs and various state and micro finances.

The Centre is planning additional policy measures for non-banking finance companies (NBFCs), along with regulatory changes in financial markets.

Finance Minister Nirmala Sitharaman on May 28 chaired a meeting of the Financial Stability and Development Council (FSDC).

At the meeting, the officials discussed volatility in the market and liquidity issues faced by NBFCs and housing finance companies (HFCs) amid the COVID-19 outbreak, Business Standard reported.

Close

Moneycontrol could not independently verify the story.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE blog for the latest updates on the novel coronavirus pandemic

Reserve Bank of India (RBI) Governor Shaktikanta Das and Securities and Exchange Board of India (SEBI) Chairman  Ajay Tyagi were present at the FSDC meeting.

SEBI suggested measures to boost domestic investment in financial markets.

"Increasing participation of domestic investors increases the linkages between the domestic markets and foreign investors, which prevents excessive volatility," a source told the publication.

The RBI raised the issue of debt markets, since many companies have sought relief since they raised money through non-convertible debentures (NCDs) which are approaching maturity, the report said.

Follow our full coverage of the COVID-19 pandemic here.
First Published on May 29, 2020 04:33 pm
Sections